Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 754.85 | 50.48 | 809.42 | ||
| High | 756.50 | 50.50 | 813.98 | ||
| Low | 737.00 | 49.07 | 798.15 | ||
| Latest | 741.92 | 49.12 | 813.24 | ||
| Change | -12.22 | -1.67 | +13.91 | ||
| % Change | -1.62% | -3.29% | +1.74% | ||
| Volume | 865,563 | 6,545,090 | 330,690 | ||
| 20-Day Average Volume | 837,248 | 3,488,754 | 329,169 | ||
| Previous Close | 754.14 | 50.79 | 799.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 773.74 | 49.46 | 827.20 | ||
| 20-Day Raw Stochastic | 5.85% | 29.41% | 39.59% | ||
| 20-Day Relative Strength | 49.00 | 52.29 | 43.48 | ||
| Weighted Alpha | +19.55 | +47.15 | +31.04 | ||
| Today's Opinion | 80% Buy | 80% Buy | 24% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.38% since 01/08/26 | -2.19% since 01/08/26 | +2.22% since 01/08/26 | ||
| Low | 737.00 on 01/15/26 | 49.07 on 01/15/26 | 770.67 on 01/12/26 | ||
| High | 821.11 on 01/09/26 | 50.87 on 01/14/26 | 816.45 on 01/09/26 | ||
| 1-Month | |||||
| %Chg | -1.42% since 12/15/25 | -0.24% since 12/15/25 | -4.43% since 12/15/25 | ||
| Low | 734.72 on 12/16/25 | 48.15 on 12/19/25 | 770.67 on 01/12/26 | ||
| High | 821.11 on 01/09/26 | 51.46 on 01/06/26 | 878.19 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | +28.71% since 10/15/25 | +12.20% since 10/15/25 | -0.29% since 10/15/25 | ||
| Low | 564.00 on 10/16/25 | 42.85 on 10/24/25 | 749.75 on 10/30/25 | ||
| High | 821.11 on 01/09/26 | 51.46 on 01/06/26 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +35.40% since 07/15/25 | +29.88% since 07/15/25 | +46.28% since 07/15/25 | ||
| Low | 541.00 on 10/13/25 | 35.45 on 07/17/25 | 558.34 on 07/16/25 | ||
| High | 821.11 on 01/09/26 | 51.46 on 01/06/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 79,259,352 | 103,530,640 | 49,213,952 | ||
| Shares Outstanding, K | 105,099 | 2,038,406 | 61,569 | ||
| Annual Sales | 14,202,000,000 | 40,095,390,000 | 2,252,040,000 | ||
| Annual Net Income | 4,412,600,000 | 3,290,590,000 | 833,040,000 | ||
| Last Quarter Sales | 3,754,300,000 | 11,520,500,000 | 1,151,340,000 | ||
| Last Quarter Net Income | 1,460,000,000 | 2,713,320,000 | 344,260,000 | ||
| 60-Month Beta | 0.39 | 0.45 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 11.83 on 10/28/25 | 1.48 on 10/29/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 01/30/26 | 02/04/26 | 02/26/26 | ||
| Most Recent Dividend | 0.880 on 11/20/25 | 0.426 on 11/14/25 | N/A | ||
| Next Ex-Dividends Date | 11/20/25 | 11/14/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.69 | 11.26 | 61.97 | ||